QURE uniQure N.V.
$44.93
uniQure N.V. (QURE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran in line with QURE's own trailing one-year pace, with 93% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
12
64 transactions
Purchases
$0
0 shares
Sales
$32.4M
886,395 shares
Net activity
-$32.4M
purchases less sales
How much of that selling was preplanned? 93% planned / 7% discretionary
10b5-1 plan sales
$30.1M
44 transactions · 742,501 shares
Discretionary sales
$2.3M
20 transactions · 143,894 shares
Largest single sale: $2.7M.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Kapusta Matthew C 3 fills | CEO, Managing Director | Sell 10b5-1 | 21,082 | $45.16 | $952.1K | 531,109 −3.8% of holding | |
| Abi-Saab Walid 2 fills | Chief Medical Officer | Sell 10b5-1 | 30,000 | $46.42 | $1.4M | 168,235 −15.1% of holding | |
| Kaye Jack 2 fills | Director | Sell 10b5-1 | 21,167 | $46.44 | $983.0K | 25,996 −44.9% of holding | |
| Abi-Saab Walid | Chief Medical Officer | Sell | 1,434 | $46.86 | $67.2K | 168,235 −0.8% of holding | |
| Kapusta Matthew C | CEO, Managing Director | Sell 10b5-1 | 28,716 | $50.02 | $1.4M | 519,227 −5.2% of holding | |
| Kapusta Matthew C | CEO, Managing Director | Sell 10b5-1 | 6,696 | $50.00 | $334.8K | 519,227 −1.3% of holding | |
| Kapusta Matthew C 2 fills | CEO, Managing Director | Sell 10b5-1 | 41,671 | $50.00 | $2.1M | 558,810 −6.9% of holding | |
| Kapusta Matthew C 6 fills | CEO, Managing Director | Sell 10b5-1 | 164,429 | $44.32 | $7.3M | 699,262 −19% of holding | |
| Balachandran Madhavan 3 fills | Director | Sell 10b5-1 | 11,685 | $45.06 | $526.5K | 49,644 −19.1% of holding | |
| Kaye Jack | Director | Sell 10b5-1 | 5,295 | $42.57 | $225.4K | 25,996 −16.9% of holding | |
| Balachandran Madhavan | Director | Sell 10b5-1 | 10,000 | $27.85 | $278.5K | 43,254 −18.8% of holding | |
| Potts Jeannette | Chief Legal Officer | Sell | 5,237 | $27.67 | $144.9K | 133,246 −3.8% of holding | |
| O'Keefe Kylie | Chief Customer & Strat Officer | Sell | 15,936 | $27.06 | $431.2K | 108,864 −12.8% of holding | |
| Gut Robert | Director | Sell | 2,726 | $27.06 | $73.8K | 32,259 −7.8% of holding | |
| Springhorn Jeremy P. | Director | Sell | 1,993 | $27.06 | $53.9K | 43,251 −4.4% of holding | |
| Jacques Rachelle Suzanne | Director | Sell | 1,993 | $27.06 | $53.9K | 33,903 −5.6% of holding | |
| POST LEONARD E | Director | Sell | 1,993 | $27.06 | $53.9K | 35,494 −5.3% of holding | |
| Kaye Jack | Director | Sell | 1,993 | $27.06 | $53.9K | 25,996 −7.1% of holding | |
| Meek David D. | Director | Sell | 1,993 | $27.06 | $53.9K | 39,747 −4.8% of holding | |
| Balachandran Madhavan | Director | Sell | 1,993 | $27.06 | $53.9K | 43,254 −4.4% of holding | |
| Gut Robert 3 fills | Director | Sell 10b5-1 | 7,552 | $26.05 | $196.7K | 32,342 −18.9% of holding | |
| Kaye Jack | Director | Sell 10b5-1 | 2,645 | $30.01 | $79.4K | 20,439 −11.5% of holding | |
| Abi-Saab Walid 2 fills | Chief Medical Officer | Sell 10b5-1 | 45,000 | $25.06 | $1.1M | 189,669 −19.2% of holding | |
| Kapusta Matthew C | CEO, Managing Director | Sell | 14,581 | $9.06 | $132.1K | 660,658 −2.2% of holding | |
| KLEMT CHRISTIAN | Chief Financial Officer | Sell | 12,000 | $9.06 | $108.7K | 226,581 −5% of holding | |
| Potts Jeannette | Chief Legal Officer | Sell | 3,412 | $9.06 | $30.9K | 138,483 −2.4% of holding | |
| Abi-Saab Walid | Chief Medical Officer | Sell | 808 | $9.06 | $7.3K | 189,669 −0.4% of holding | |
| Kapusta Matthew C | CEO, Managing Director | Sell | 34,437 | $9.95 | $342.6K | 604,639 −5.4% of holding | |
| KLEMT CHRISTIAN | Chief Financial Officer | Sell | 12,532 | $9.95 | $124.7K | 198,981 −5.9% of holding | |
| Potts Jeannette | Chief Legal Officer | Sell | 8,578 | $9.95 | $85.4K | 106,495 −7.5% of holding | |
| Abi-Saab Walid | Chief Medical Officer | Sell | 1,660 | $9.95 | $16.5K | 148,777 −1.1% of holding | |
| Kapusta Matthew C | CEO, Managing Director | Sell | 12,378 | $23.86 | $295.3K | 639,076 −1.9% of holding | |
| KLEMT CHRISTIAN | Chief Financial Officer | Sell | 6,217 | $23.86 | $148.3K | 211,513 −2.9% of holding | |
| Gut Robert 3 fills | Director | Sell 10b5-1 | 25,613 | $24.62 | $630.5K | 40,645 −38.7% of holding | |
| Kaye Jack | Director | Sell 10b5-1 | 6,390 | $27.28 | $174.3K | 20,439 −23.8% of holding | |
| Gut Robert 2 fills | Director | Sell 10b5-1 | 31,434 | $27.26 | $856.9K | 55,739 −36.1% of holding | |
| Kaye Jack 3 fills | Director | Sell 10b5-1 | 38,810 | $30.34 | $1.2M | 20,439 −65.5% of holding | |
| KLEMT CHRISTIAN | Chief Financial Officer | Sell 10b5-1 | 15,000 | $55.00 | $825.0K | 217,730 −6.4% of holding | |
| Kapusta Matthew C 5 fills | CEO, Managing Director | Sell 10b5-1 | 226,316 | $41.46 | $9.4M | 826,454 −21.5% of holding | |
| KLEMT CHRISTIAN | Chief Financial Officer | Sell 10b5-1 | 3,000 | $40.04 | $120.1K | 217,730 −1.4% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.